The COPCOV Trial’s position statement on “A living WHO guideline on drugs to prevent COVID-19.”
Following WHO recommendations against the use of hydroxychloroquine in the prevention of COVID-19, including its use in controlled trials, we are reviewing the guideline and available evidence. We are concerned that this judgement from the authors of the guideline is scientifically unsound.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2021), The Lancet, 397, 1637 - 1645
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
Thriemer K. et al, (2021), PLoS medicine, 18
The prevention and treatment of Plasmodium vivax malaria.
Chu CS. and White NJ., (2021), PLoS medicine, 18